Sage Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sage Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2015 to Q3 2024.
  • Sage Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -50.3 %, a 19.8% increase year-over-year.
  • Sage Therapeutics, Inc. annual Return On Equity for 2023 was -58 %, a 56.7% decline from 2022.
  • Sage Therapeutics, Inc. annual Return On Equity for 2022 was -37 %, a 51.6% decline from 2021.
  • Sage Therapeutics, Inc. annual Return On Equity for 2021 was -24.4 %, a 144% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -50.3 +12.4 +19.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -60.4 -10.6 -21.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -60.9 -18.6 -43.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -58 -21 -56.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -62.7 -29.9 -91.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -49.8 -19.7 -65.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -42.3 -15.1 -55.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -37 -12.6 -51.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -32.8 -65.5 -200% Jul 1, 2022 Sep 30, 2022
Q2 2022 -30.1 -70.1 -175% Apr 1, 2022 Jun 30, 2022
Q1 2022 -27.2 -73.8 -158% Jan 1, 2022 Mar 31, 2022
Q4 2021 -24.4 -80.6 -144% Oct 1, 2021 Dec 31, 2021
Q3 2021 32.7 +100 Jul 1, 2021 Sep 30, 2021
Q2 2021 40 +108 Apr 1, 2021 Jun 30, 2021
Q1 2021 46.6 +110 Jan 1, 2021 Mar 31, 2021
Q4 2020 56.1 +116 Oct 1, 2020 Dec 31, 2020
Q3 2020 -67.4 -7.37 -12.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -67.7 -11.6 -20.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -63.1 -19.7 -45.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 -59.8 -22.4 -60% Oct 1, 2019 Dec 31, 2019
Q3 2019 -60 -28.5 -90.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -56.1 -22.7 -67.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -43.5 +14.3 +24.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -37.4 +48.8 +56.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -31.5 +57.9 +64.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 -33.4 +31.5 +48.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -57.7 -3.17 -5.81% Jan 1, 2018 Mar 31, 2018
Q4 2017 -86.1 -38.2 -79.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 -89.5 -43 -92.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 -64.9 -13.4 -26.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -54.6 -5.21 -10.6% Jan 1, 2017 Mar 31, 2017
Q4 2016 -47.9 +6.4 +11.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 -46.5 +2.12 +4.36% Jul 1, 2016 Sep 30, 2016
Q2 2016 -51.5 -7.41 -16.8% Apr 1, 2016 Jun 30, 2016
Q1 2016 -49.4 +7.38 +13% Jan 1, 2016 Mar 31, 2016
Q4 2015 -54.3 Oct 1, 2015 Dec 31, 2015
Q3 2015 -48.6 Jul 1, 2015 Sep 30, 2015
Q2 2015 -44 Apr 1, 2015 Jun 30, 2015
Q1 2015 -56.7 Jan 1, 2015 Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.